Samalin Investment Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Samalin Investment Counsel's MRK Position: Q2 2026 in Review
Samalin Investment Counsel increased its Merck (MRK) stake by 4.5% in Q2 2026, buying an estimated $59.8K and bringing the position to 11,932 shares worth $1.53M. The position accounts for 0.48% of the portfolio, ranked #54.
Samalin Investment Counsel first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Samalin Investment Counsel held 11,932 shares of Merck worth $1.53M as of Q2 2026.
- Samalin Investment Counsel bought 511 Merck shares in Q2 2026, an estimated $59.8K.
- Merck made up 0.48% of Samalin Investment Counsel's portfolio in Q2 2026, its #54 holding.
- Samalin Investment Counsel first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.